Breaking News
September 25, 2018 - New therapeutic vaccine helps immune cells fight HPV-related head and neck cancer
September 25, 2018 - Environmentally-induced gene activity influences IQ test performance
September 25, 2018 - Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI
September 25, 2018 - FDA Approves Copiktra (duvelisib) Capsules for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma
September 25, 2018 - Medical device company settles US case over false claims
September 25, 2018 - Trying to get answers: One woman’s quest for a diagnosis
September 25, 2018 - Lung cancer patients treated with invasive surgery more likely to become chronic opioid users
September 25, 2018 - Oxford VR raises £3.2m to boost innovation in VR for mental health problems
September 25, 2018 - Gene therapy approach could help treat mitochondrial diseases
September 25, 2018 - Few Yogurt Products Qualify As Low-Sugar
September 25, 2018 - Eye disease can cause blindness, and it’s on the rise
September 25, 2018 - Pawnshop density linked to gun-related suicides, Stanford study finds
September 25, 2018 - Pioneering procedure for common prostate condition offered by The London Clinic
September 25, 2018 - Number of people with respiratory diseases likely to increase if UK air pollution remains unchecked
September 25, 2018 - FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial
September 25, 2018 - New program to reduce harmful stress effectively improves mood in cancer patients
September 24, 2018 - Florence’s Lingering Threat: Mold – Drugs.com MedNews
September 24, 2018 - For professional baseball players, faster hand-eye coordination linked to batting performance
September 24, 2018 - Bill for later school start times is defeated, but Stanford sleep specialist isn’t
September 24, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 24, 2018 - Successful recovery from addiction means more than achieving abstinence
September 24, 2018 - New nanoplatform technology may reverse drug-resistance in renal cell carcinoma
September 24, 2018 - October 1918 marks the centenary of Spanish Flu that claimed more lives than World War I
September 24, 2018 - LGBT community reports more number of poor mental health days than general population
September 24, 2018 - New research suggests power of zebrafish as tool for cancer drug discovery
September 24, 2018 - New study finds height as possible risk factor for developing varicose veins
September 24, 2018 - Researchers compare weight loss results of online and in-person diabetes prevention program
September 24, 2018 - New HER2 PET Study Uses Affibody’s ABY-025 Tracer to Individualize Breast Cancer Treatment
September 24, 2018 - Drug combination offers more effective care for patients suffering miscarriage
September 24, 2018 - Tallness linked to varicose veins, Stanford study says
September 24, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 24, 2018 - Ecstasy drug makes octopuses more social
September 24, 2018 - Immediate compression therapy could cut risk of complications after deep-vein thrombosis
September 24, 2018 - Transcatheter mitral valve repair reduces mortality for patients with mitral regurgitation
September 24, 2018 - First intracranial aneurysm patients treated with BRAVO Flow Diverter after CE mark approval
September 24, 2018 - ‘Physicians of the mouth’? Dentists absorb the medical billing drill
September 24, 2018 - People more likely to believe those with confident tone of voice than with accent
September 24, 2018 - Harmony Biosciences Presents 5-Year Data On Pitolisant At International Narcolepsy Symposium
September 24, 2018 - Blood test may identify gestational diabetes risk in first trimester
September 24, 2018 - Height may be risk factor for varicose veins | News Center
September 24, 2018 - King’s commemorates opening of new NMR facility with one-day symposium
September 24, 2018 - Eisai receives approval for partial label change of DC Bead device for transcatheter arterial embolization
September 24, 2018 - Using multi-level approach to reduce underage drinking among youths on rural reservations
September 24, 2018 - High-resolution genomic map gives scientists unprecedented view of brain development
September 24, 2018 - Researchers find impact of neurobehavioral symptoms on employment in adults with TBI
September 24, 2018 - Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD
September 24, 2018 - First evaluation of benefits, harms of Alzheimer’s screening for family members of older adults
September 24, 2018 - Ancora Heart announces positive data of study evaluating AccuCinch Ventricular Repair System
September 24, 2018 - Children of mothers using cannabis may start using it at an earlier age, finds study
September 24, 2018 - Gilead Sciences plans to launch authorized generic versions of Epclusa and Harvoni in the US
September 24, 2018 - Most patients who underwent transcatheter valve replacement experience prosthesis-patient mismatch
September 24, 2018 - Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone
September 24, 2018 - New study provides basis for Air Canada to change its facial hair policy for aircrew
September 24, 2018 - Infant walkers lead to thousands of emergency visits for babies
September 24, 2018 - Genes predicting person’s height may provide clues about causes of varicose veins
September 24, 2018 - EPA Plan Will Maintain Carbon Emissions From Power Plants
September 24, 2018 - Characterizing pig hippocampus could improve translational neuroscience
September 24, 2018 - Element3 Health reports social and mental engagement play key role in overall health
September 24, 2018 - Paralympic medalists support Fight for Sight’s unique virtual event
September 24, 2018 - ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma
September 24, 2018 - Public awareness of urological conditions found to be alarmingly low across Europe
September 24, 2018 - Fitter Folks Suffer Milder Strokes: Study
September 24, 2018 - Novel botulinum toxin compound relieves chronic pain
September 24, 2018 - CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents
September 24, 2018 - National Friendly’s private medical insurance is a hit with women living in the South East
September 24, 2018 - Academics receive prestigious awards for achievements in blood pressure research
September 24, 2018 - Obese pregnant women can restrict weight gain safely with proper nutrition guidance
September 24, 2018 - CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer
September 24, 2018 - China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma
September 24, 2018 - A new approach for finding Alzheimer’s treatments
September 24, 2018 - USC research uncovers previously unknown genetic risk factor for dementia
September 24, 2018 - Study examining mental health among students finds significant disparities in treatment across race
September 24, 2018 - Breakthrough discovery paves way for future test to identify drowsy drivers
September 24, 2018 - Transcatheter mitral-valve repair in patients with heart failure
September 24, 2018 - Study opens new avenues for treatment of Laing distal myopathy
September 24, 2018 - Stroke Facts | cdc.gov
September 24, 2018 - Sarcolipin tricks muscle cells into using more energy, burning fat
September 24, 2018 - Enrollment in opioid controlled substance agreement reduces primary care visits
September 24, 2018 - UTA researchers patent new smart seat cushion technology that helps prevent painful ulcers
September 24, 2018 - Second HPV-Related Primary Cancers Common in Survivors
At-Home STI Testing Increased Uptake in British Study

At-Home STI Testing Increased Uptake in British Study

image_pdfDownload PDFimage_print

Action Points

  • At-home testing for sexually transmitted infections (STIs) may help increase uptake rates and should be considered as a complement to usual care.
  • Note that time to test was shorter in the e-STI group compared with the control group, but there were no differences for time to treatment.

At-home testing for sexually transmitted infections (STIs) using kits ordered online may help increase uptake rates and should be considered as a complement to usual care, reported researchers.

In a randomized trial involving more than 2,000 people in London, uptake of STI testing at 6 weeks was higher among those who used “e-STI” testing compared with those who used existing services at health clinics (50.0% versus 26.6%, relative risk 1.87, 95% CI 1.63-2.15, P<0.001), wrote Emma Wilson, MSc, of the London School of Hygiene & Tropical Medicine, and colleagues online in PLOS Medicine.

“E-STI testing is currently being implemented in the U.K. as one measure to meet increasing demand for STI testing, but there is surprisingly little evidence on whether it successfully encourages uptake,” said Wilson. “Our study, the first of its kind, aimed to investigate the effectiveness of e-STI testing for syphilis, HIV, chlamydia, and gonorrhea.”

Co-author Caroline Free, MBChB, PhD, of the London School of Hygiene & Tropical Medicine, explained that while sexual health clinics play an important role in community health, some people may find them inconvenient or stigmatizing.

“Our study showed that when e-STI testing was made available alongside face-to-face services, the number of people getting tested for STIs nearly doubled,” stated Free.

Wilson and colleagues recruited 2,072 participants, ages 16–30 years, from the London boroughs of Lambeth and Southwark from Nov. 24, 2014, to Aug. 31, 2015. All participants had at least one sexual partner in the last 12 months, were willing to take an STI test, and had internet access.

The researchers randomized participants to a control group who received a text message with a link listing the locations, contact details, and websites of seven local sexual health clinics, or to e-STI testing using a service called SH:24.

Those in the latter group were directed to a website for ordering sample collection kits, which they then returned for testing for chlamydia, gonorrhea, HIV, and syphilis. Test results and information about safe sex were delivered via text message or telephone.

Participants in both groups were allowed to use other services or interventions at their discretion during the study period.

Wilson and colleagues found that 2.8% of participants in the intervention group were diagnosed with an STI compared with 1.4% in the control group. The proportion of participants treated was 1.1% versus 0.7%, respectively.

Time to test was shorter in the e-STI group compared with the control group (28.8 days versus 36.5 days, P<0.001), but there were no differences for time to treatment (83.2 days versus 83.5 days).

The researchers also reported that that among participants who completed an STI test at 6 weeks, 4.3% (19 out of 439; 95% CI 2.8%-6.7%) tested positive for an STI in the e-STI group compared with 4.6% (8 out of 173; 95% CI 2.3%-9.0%) in the control group.

“As sexual health services develop we would like to see further work aligning online and clinic based services,” commented another study author, Paula Baraitser, MSc, of Kings College London. “Going forward we advise joint commissioning of these different modalities of care to ensure that users are able to move easily from one to another according to their health care needs, allowing continuity of care.”

A leading study limitation was the inability to recruit the target of 3,000 participants, leaving the study underpowered to detect differences in STI diagnoses and STI cases treated. The team also noted the use of self-reported data, as well as that those who registered for the study already had a greater interest in STI testing compared to those who declined, thus limiting the study’s generalizability.

The study was funded by Guy’s and St Thomas’ Charity, as part of their award to SH:24.

  • Reviewed by
    Robert Jasmer, MD Associate Clinical Professor of Medicine, University of California, San Francisco and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2017-12-27T17:15:00-0500

Tagged with:

About author

Related Articles